Post-therapy B Regulatory Cells Might early Predict Relapse in Hodgkin Lymphoma.

Giudice, Valentina; Pezzullo, Luca; Ciancia, Giuseppe; D'Addona, Matteo; D'Alto, Francesca; Gorrese, Marisa; Cuffa, Bianca; Selleri, Carmine

Giudice, Valentina; Pezzullo, Luca; Ciancia, Giuseppe; D'Addona, Matteo; D'Alto, Francesca; Gorrese, Marisa; Cuffa, Bianca; Selleri, Carmine.

Afiliación

Giudice V; Department of Medicine, Surgery, and Dentistry "Scuola Medica Salernitana", University of Salerno, Baronissi, Italy.
Pezzullo L; Hematology and Transplant Center, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy.
Ciancia G; Hematology and Transplant Center, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy.
D'Addona M; Anatomy Patology, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy.
D'Alto F; Hematology and Transplant Center, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy.
Gorrese M; Hematology and Transplant Center, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy.
Cuffa B; Hematology and Transplant Center, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy.
Selleri C; Hematology and Transplant Center, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy.

Mediterr J Hematol Infect Dis ; 14(1): e2022042, 2022.

Article en En | MEDLINE | ID: mdl-35615322

Palabras clave

B regulatory cells; Hodgkin lymphoma; Immune system

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Mediterr J Hematol Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google